Department Of Biotechnology
- All
- News
- Videos
-
Applications Invited For Biotechnology Entrance Exam
Graduate Aptitude Test- Biotechnology (GAT-B)/ Biotechnology Eligibility Test (BET) is a national level entrance examination for admission to Biotechnology courses.
-
West Bengal Startup Develops New Device That Can Produce Oxygen From Water
A startup in West Bengal has come out with a device that produces oxygen from water just by pressing of a switch, the founders of the technology claimed. 'OM Redox', the device developed by Solaire Initiatives, which is incubated in the Webel-BCC&I Tech Incubation Centre, provides pure oxygen from water, they said.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Government Says 5G Roll-Out Won't Be A Health Hazard
Government has said that stricter norms for safety from electric and magnetic fields emissions from mobile towers in India have been adopted.
-
Medical Body ICMR-NICED Proposes Research On Oral Covid Vaccine
Kolkata-based medical research body ICMR-NICED has submitted a proposal to the Department of Biotechnology under the Union Ministry of Science and Technology for research on an oral Covid vaccine, a senior official of the institute said today.
-
Department Of Biotechnology Extends Application Deadline For Star College Scheme
The scheme is aimed at improving practical training in Science courses like Botany, Zoology, Chemistry, Microbiology, Physics, Biochemistry, Biotechnology, Bioinformatics, Mathematics, Electronics, Computer Science, etc.
-
National Institute Of Immunology Gets Trademark For India's First Indigenous Tumor Antigen SPAG9
The SPAG9 antigen developed by the National Institute of Immunology (NII) has received the ASPAGNIITM trademark, the Department of Biotechnology (DBT) said on Friday.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
Covaxin's Production Capacity 150 Million Doses A Year: Centre
The estimated manufacturing capacity of COVID-19 vaccine, Covishield, is 70-100 million doses per month, while the indigenously developed Covaxin has a planned production capacity of 150 million doses per year, the Department of Biotechnology told a parliamentary panel.
-
Zydus Cadila Gets Nod For Phase 3 Trials Of Its Covid Vaccine Candidate
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of Biotechnology said on Sunday.
-
Over 100 Experts From Friendly Nations Trained For Clinical Trials Of Indian Covid Vaccine: Official
Over 100 experts from friendly neighbouring nations have so far been trained to strengthen capacities in their countries for facilitating phase-3 clinical trials of Indian COVID-19 vaccine, a senior official of the department of biotechnology said on Wednesday.
-
Finance Minister Announces Rs 900 Crore Grant For COVID-19 Vaccine Research
Finance Minister Nirmala Sitharman today announced a Rs 900 crore grant to the Department of Biotechnology for COVID-19 vaccine research.
-
India Launches Program To Strengthen Clinical Trial Research Of Vaccines In Neighbouring Nations
Amid the COVID-19 pandemic, India has started a "science diplomacy" initiative by launching a programme to strengthen the capacity of clinical trial research of vaccines in neighbouring countries, the Department of Biotechnology said today.
-
Applications Invited For Biotechnology Entrance Exam
Graduate Aptitude Test- Biotechnology (GAT-B)/ Biotechnology Eligibility Test (BET) is a national level entrance examination for admission to Biotechnology courses.
-
West Bengal Startup Develops New Device That Can Produce Oxygen From Water
A startup in West Bengal has come out with a device that produces oxygen from water just by pressing of a switch, the founders of the technology claimed. 'OM Redox', the device developed by Solaire Initiatives, which is incubated in the Webel-BCC&I Tech Incubation Centre, provides pure oxygen from water, they said.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Government Says 5G Roll-Out Won't Be A Health Hazard
Government has said that stricter norms for safety from electric and magnetic fields emissions from mobile towers in India have been adopted.
-
Medical Body ICMR-NICED Proposes Research On Oral Covid Vaccine
Kolkata-based medical research body ICMR-NICED has submitted a proposal to the Department of Biotechnology under the Union Ministry of Science and Technology for research on an oral Covid vaccine, a senior official of the institute said today.
-
Department Of Biotechnology Extends Application Deadline For Star College Scheme
The scheme is aimed at improving practical training in Science courses like Botany, Zoology, Chemistry, Microbiology, Physics, Biochemistry, Biotechnology, Bioinformatics, Mathematics, Electronics, Computer Science, etc.
-
National Institute Of Immunology Gets Trademark For India's First Indigenous Tumor Antigen SPAG9
The SPAG9 antigen developed by the National Institute of Immunology (NII) has received the ASPAGNIITM trademark, the Department of Biotechnology (DBT) said on Friday.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
Covaxin's Production Capacity 150 Million Doses A Year: Centre
The estimated manufacturing capacity of COVID-19 vaccine, Covishield, is 70-100 million doses per month, while the indigenously developed Covaxin has a planned production capacity of 150 million doses per year, the Department of Biotechnology told a parliamentary panel.
-
Zydus Cadila Gets Nod For Phase 3 Trials Of Its Covid Vaccine Candidate
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of Biotechnology said on Sunday.
-
Over 100 Experts From Friendly Nations Trained For Clinical Trials Of Indian Covid Vaccine: Official
Over 100 experts from friendly neighbouring nations have so far been trained to strengthen capacities in their countries for facilitating phase-3 clinical trials of Indian COVID-19 vaccine, a senior official of the department of biotechnology said on Wednesday.
-
Finance Minister Announces Rs 900 Crore Grant For COVID-19 Vaccine Research
Finance Minister Nirmala Sitharman today announced a Rs 900 crore grant to the Department of Biotechnology for COVID-19 vaccine research.
-
India Launches Program To Strengthen Clinical Trial Research Of Vaccines In Neighbouring Nations
Amid the COVID-19 pandemic, India has started a "science diplomacy" initiative by launching a programme to strengthen the capacity of clinical trial research of vaccines in neighbouring countries, the Department of Biotechnology said today.
